Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Recovery of Acute Ophthalmoplegia After Hyaluronic Acid Filler Injections to the Temples: A Case Report and Review of the Literature Publisher



Tabatabaei FS1 ; Azimi A1 ; Tabatabaei SS2 ; Pakdaman H3
Authors

Source: Archives of Plastic Surgery Published:2022


Abstract

Soft tissue filler injection is the second most common nonsurgical cosmetic procedure. Despite the safety of fillers, as use has grown, so has the number of patients affected by adverse events. Ophthalmoplegia following cosmetic filler injection is a rare complication, mostly occurring after injection to the glabella, nasolabial fold, periorbital, and lateral nasal site. In all cases where ophthalmoplegia has been reported following fillers, patients have simultaneously experienced vision loss and other ocular symptoms. We report a case of isolated acute ophthalmoplegia following hyaluronic acid injection solely in the temple region. A 40-year-old woman, 3 hours after the procedure, presented to our hospital with left eye ophthalmoplegia, ptosis, and hypotropia. Treatment started with hyaluronidase, steroids, and anticoagulants. After 4 weeks, left eye ophthalmoplegia remained unchanged, and through a 10-week follow-up, all left ocular movements improved, and only mild hypotropia and ptosis persisted. This case report shows that ophthalmoplegia may also happen with temple region filler injections. We also review available prevention techniques and treatments to avoid such complications when performing soft tissue fillers for gaunt appearance correction. © 2022 Korean Society of Plastic and Reconstructive Surgeons. All rights reserved.
Other Related Docs
4. Disaster in Cosmetic Surgery: Inadvertent Formalin Injection During Blepharoplasty, Ophthalmic Plastic and Reconstructive Surgery (2015)
9. Uveitis-Induced Refractory Ocular Hypotony Managed With High-Dose Latanoprost, Journal of Ophthalmic and Vision Research (2020)